Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

MedCrypt Raises $1.9 Million in Funding, Round Led by Eniac Ventures

Funds will accelerate commercial deployment of cryptographically embedded cybersecurity software for medical devices

ENCINITAS, Calif- MedCrypt, a medical device cybersecurity technology provider, today announces $1.9 million in new funding. The seed round was led by Eniac Ventures, with participation from Sway Ventures, Nex Cubed, Oronoco Investments and Friedman BioVentures.

The financing will accelerate the commercial deployment of cryptographically embedded cybersecurity software for medical device makers, which includes customers Reflexion Medical, QuiO and more.

“The FDA is cracking down on medical device cybersecurity by releasing more robust regulations by which medical device vendors and healthcare delivery organizations are required to abide,” says Mike Kijewski, CEO and co-founder, MedCrypt. “Our solution lets these organizations protect their devices – and patients – with just a few lines of code. We’re thrilled to gain additional funding and support to help accelerate our technology.”

“Cyber threats are an exponentially increasing problem that is threatening businesses, governments, households and, in healthcare, even lives,” said Tim Young, founding general partner at Eniac Ventures. “MedCrypt has already set itself apart with a seasoned technical team and proprietary technology that is helping the largest medical device makers in the world protect their devices and the underlying users. Our team is excited to support Mike Kijewski and Eric Pancost in continuing to build out MedCrypt as the most comprehensive security layer for healthcare IT.”

Cyber crime damage costs are projected to reach $6 trillion annually by year 2021, and last year the healthcare industry reported more than 447 breaches. MedCrypt’s cryptographically embedded security software helps medical device vendors build products that are Secure By Design and monitor behavior of these devices once they are deployed. MedCrypt-enabled devices will be ensured they meet the FDA cybersecurity regulations and will provide the hospital or medical facility security team with a more robust solution to encrypt, monitor and protect in real-time.

This additional financing brings the company’s total to-date funding to $3 million. Existing additional investors include Safeguard Scientifics and Long River Ventures. MedCrypt recently won the HIMSS Venture Connect startup contest, held at HIMSS18 earlier this year. The company was also named a San Diego Venture Group 2018 “Cool Company.”